Coronary Artery DiseaseNCT01932411
Factors Affect Outcomes in Cardiovascular Surgery
An observational study of Coronary Artery Disease and Valvular Diseases, run by University of California, Davis at 1 site in United States.
Trial summary
Identify factors that contribute to perioperative morbidity and mortality in patients undergoing cardiac surgery that involves cardiopulmonary bypass. Identify factors that affect perioperative morbidity and mortality in patients undergoing cardiac surgery. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Coronary Artery Disease, Valvular Diseases, Vascular Diseases
- How many people
- 5,000 participants
- Where
- 1 siteUnited States
- Study dates
- Jul 2013to 1 Dec 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: patients undergoing cardiovascular surgeries
Who may be able to join
- Patients greater than or equal to 18 years old that underwent cardiovascular surgery at UC Davis Medical Center from 01/01/2001 to 07/15/2013.
- Patients will only be included that underwent cardiovascular surgeries with or without cardiopulmonary bypass.
Who cannot join
- Patients that did not undergo cardiovascular surgeries and age< 18 years old will be excluded from the study.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
University of California Davis Health System
Sacramento, California, 95817
Hong Liu, MD, 916-734-5031, hong.liu@ucdmc.ucdavis.edu
Sunita Randhawa, 916-734-5394, srandhawa@ucdavis.edu
About this study
Official title: Factors That Affect the Outcomes of Cardiothoracic and Vascular Surgery
Identify factors that contribute to perioperative morbidity and mortality in patients undergoing cardiac surgery that involves cardiopulmonary bypass.
Identify factors that affect perioperative morbidity and mortality in patients undergoing cardiac surgery.
Read the detailed description
Identify factors that affect perioperative morbidity and mortality in patients undergoing cardiac surgery.
Here are some examples, but may not limited the following factors:
- demographic data
- perioperative medications
- comorbidity
- Medical subject headings
- Coronary Artery Disease, Vascular Diseases
What is being measured
The primary outcome is the main question the study is designed to answer.
all cause mortality
in hospital, 30 day, one year and longer
Measured: 12 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Aug 2013 (estimated)
- Study startJul 2013
- Primary completion1 Dec 2026 (estimated)
- Study completion1 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Coronary Artery DiseaseStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 5,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of California, Davis
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Hong Liu, M.D., Principal investigator, University of California, Davis, Department of Anesthesiology and Pain Medicine
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01932411
- Sponsor's protocol ID
- 483753
- Status last verified
- Sep 2026
- First submitted
- 27 Aug 2013
- Last updated
- 14 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 14 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Factors That Affect the Outcomes of Cardiothoracic and Vascular Surgery
- ClinicalTrials.gov ID
- NCT01932411
- Acronym / sponsor ID
- 483753
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 5,000 participants (estimated)
- Lead sponsor
- University of California, DavisUniversity, hospital or other
- Study start
- Jul 2013
- Primary completion
- 1 Dec 2026 (estimated)
- Study completion
- 1 Dec 2026 (estimated)
- First posted
- 30 Aug 2013 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Identify factors that contribute to perioperative morbidity and mortality in patients undergoing cardiac surgery that involves cardiopulmonary bypass.
Identify factors that affect perioperative morbidity and mortality in patients undergoing cardiac surgery.
Detailed description
Identify factors that affect perioperative morbidity and mortality in patients undergoing cardiac surgery.
Here are some examples, but may not limited the following factors:
- demographic data
- perioperative medications
- comorbidity
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- patients undergoing cardiovascular surgeries
Key inclusion criteria (2 listed)
- Patients greater than or equal to 18 years old that underwent cardiovascular surgery at UC Davis Medical Center from 01/01/2001 to 07/15/2013.
- Patients will only be included that underwent cardiovascular surgeries with or without cardiopulmonary bypass.
Key exclusion criteria (1 listed)
- Patients that did not undergo cardiovascular surgeries and age< 18 years old will be excluded from the study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
all cause mortality
Time frame: 12 years
in hospital, 30 day, one year and longer
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Sep 2026.
- Learn more or sign up for the study here!Link provided by the sponsor.
Related trials for Coronary Artery Disease
Active, not recruiting
Comparison of Vessel-FFR Versus FFR in Intermediate Coronary Stenoses
Coronary Artery Disease, Coronary Artery Stenoses
Recruiting
Lifewise Preventive Video Education in Primary Care
Prevention Harmful Effects, Health Maintenance
RecruitingPhase 4
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Recruiting
Multivessel Balloon Occlusion to Investigate Obstructive Coronary Artery Disease and aNgina
Stable Angina, Multivessel Coronary Artery Disease
RecruitingObservational study
Cardiovascular Acoustics for Early Disease Detection
Valvular Heart Disease, Coronary Artery Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Hong Liu, M.D. principal investigator
University of California, Davis, Department of Anesthesiology and Pain Medicine
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Coronary Artery Disease and Valvular Diseases, run by University of California, Davis at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 14 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Hong Liu, M.D. (916-734-2949, hualiu@ucdmc.ucdavis.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
all cause mortality (time frame: 12 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Sep 2026; AzTrials last refreshed its copy on 30 Oct 2026.